Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002049575-24-000001
Filing Date
2024-12-20
Accepted
2024-12-20 15:17:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9561
  Complete submission text file 0002049575-24-000001.txt   11396
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Subject) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92230 | Film No.: 241567592
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address TWO TOWNE SQUARE SUITE 810 SOUTHFIELD MI 48076
Business Address TWO TOWNE SQUARE SUITE 810 SOUTHFIELD MI 48076 248-723-6650
V-CO Investors LLC (Filed by) CIK: 0002049575 (see all company filings)

EIN.: 992878853 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SCHEDULE 13G